Pacing and Clinical Electrophysiology · 2008 · 26 citations · 28 references
MedicineCardiologyPharmacologyClinical CardiologyElectrophysiologyInterventional CardiologyAtrial FibrillationCardiac ArrhythmiasCardiac BiomarkersCardiac Risk AssessmentArrhythmia BiomarkersArrhythmia RecurrenceAtrial Fibrillation Risk AssessmentEarly Detection Of RecurrenceEarly Recurrence DetectionEarly Recurrence PredictionElectrical CardioversionRecurrence
BACKGROUND: The purpose of this study was to determine whether high asymmetric dimethylarginine (ADMA) levels could predict early recurrence of atrial fibrillation (AF) after successful electrical cardioversion (CV). METHODS: Seventy patients with persistent AF, but without known heart disease, who underwent elective electrical CV were enrolled. Blood samples for ADMA determination were drawn from all patients just before the CV. RESULTS: The study population comprised 64 patients (men 73%, age 62.56 +/- 7.72 years, duration of AF 6.00 +/- 1.90 months) in whom sinus rhythm was restored. After 1-month follow-up, 30 (47%) patients had recurrence of AF. The median ADMA concentration was significantly higher in patients with AF recurrence (1.93 micromol/L vs 1.43 micromol/L; P = 0.001). AF recurrence was associated with higher pre-CV ADMA levels (odds ratio [OR]= 4.20; 95% confidence interval [CI], 1.44-12.22; P = 0.001). On multivariate analysis, ADMA was the only independent predictor of arrhythmia recurrence (OR = 4.19; 95%CI, 1.12-15.77; P = 0.034). CONCLUSION: Our data suggest that high levels of ADMA are associated with an increased risk of AF recurrence within 1 month after electrical CV, supporting the hypothesis that ADMA might participate in the process of atrial remodeling.
28
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
A. Leone, S. Moncada, Patrick Vallance et al. · The Lancet · 1992 · 2.1K citations
Medicine, Nephrology, Pharmacology +11
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation
Andrea Frustaci, Cristina Chimenti, Fulvio Bellocci et al. · Circulation · 1997 · 1.4K citations
Medicine, Cardiology, Pathology +8
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction
Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text
Medicine, Cardiology, Pharmacology +12
Endogenous Nitric Oxide Synthase Inhibitor
Hiroshi Miyazaki, Hidehiro Matsuoka, John P. Cooke et al. · Circulation · 1999 · 764 citations · Full text
Medicine, Cardiology, Pharmacology +15